DUBLIN, March 3, 2017 /PRNewswire/ -- Endo International plc (NASDAQ / TSX: ENDP) today announced that it has applied tothe Toronto Stock Exchange (the "TSX") to have its ordinary shares delisted from the TSX at the close of business on March 17, 2017. This application is being made due to the limited trading volume of Endo's ordinary shares
About Endo International plc Endo International plc (NASDAQ / TSX: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering high-quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endo-international-plc-to-delist-ordinary-shares-from-the-toronto-stock-exchange-300417920.html
SOURCE Endo International plc
Subscribe to our Free Newsletters!